- Home
- ACIU vs MFIN Comparison
ACIU vs MFIN Comparison
Compare ACIU & MFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ACIU | MFIN |
|---|---|---|
| Founded | 2003 | 1995 |
| Country | Switzerland | United States |
| Employees | 122 | 179 |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 221.9M | 220.3M |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | ACIU | MFIN |
|---|---|---|
| Price | $2.14 | $10.01 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $10.00 | ★ $12.00 |
| AVG Volume (30 Days) | ★ 256.1K | 102.4K |
| Earning Date | 05-12-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 5.18% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $706.75 | N/A |
| Revenue Next Year | $321.13 | $0.02 |
| P/E Ratio | ★ N/A | $6.21 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.03 | $7.85 |
| 52 Week High | $4.00 | $11.00 |
Technical Indicators
Market Signals| Indicator | ACIU | MFIN |
|---|---|---|
| Relative Strength Index (RSI) | 36.96 | 51.97 |
| Support Level | $2.15 | $9.73 |
| Resistance Level | $2.66 | $10.34 |
| Average True Range (ATR) | 0.15 | 0.30 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 11.11 | 29.82 |
Price Performance
Historical ComparisonAbout ACIU AC Immune SA
AC Immune SA is a clinical stage biopharmaceutical company advancing a portfolio of programs strategically focused on pioneering Precision Medicine for neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company has one segment. The company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About MFIN Medallion Financial Corp.
Medallion Financial Corp is a finance company that originates and services loans in various industries. The four operating segments are, (1) recreation, (2) home improvement, (3) commercial and (4) taxi medallion The company generates maximum revenue from the Recreation segment. The company's geographic Concentrations are in united states diversified in California, Wisconsin, New York, Texas and others.